Polymerase chain reaction

LaunchWorks and Canadienzyme Collaboration Results in New Product for Diagnostic Testing

Retrieved on: 
Wednesday, May 26, 2021
Laboratory techniques, Molecular biology, Natural sciences, Articles, Science and technology, Polymerase chain reaction, Biotechnology, Amplifiers, Real-time polymerase chain reaction

In doing so, they created a made-in-Canada RT-qPCR testing reagent that works as well as international versions on patient samples.

Key Points: 
  • In doing so, they created a made-in-Canada RT-qPCR testing reagent that works as well as international versions on patient samples.
  • The new RT-qPCR Master Mix developed by Canadienzyme is now available through LaunchWorks in the US and Canada.
  • Launchworks is committed to accelerating life science product commercialization by optimizing every step of the manufacturing process.
  • Located in Anjou Quebec and Beverly MA, Launchworks has been producing molecular diagnostic test kits for the past 12 years.

Applied DNA Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Rapidly Identify Mutations and Probable Variants

Retrieved on: 
Wednesday, May 26, 2021
Health, Genetics, Other Science, Research, Science, Pharmaceutical, Biotechnology, Biotechnology, Biology, Life sciences, Branches of biology, Molecular biology, Laboratory techniques, Amplifiers, Nucleic acids, Polymerase chain reaction, DNA sequencing, DNA, Real-time polymerase chain reaction

The SGS Panel has not been approved or authorized to diagnose, ameliorate and/or detect any disease by any U.S. or international regulatory authority.

Key Points: 
  • The SGS Panel has not been approved or authorized to diagnose, ameliorate and/or detect any disease by any U.S. or international regulatory authority.
  • Applied DNA is commercializing LinearDNA, its proprietary, large-scale polymerase chain reaction (PCR)-based manufacturing platform that allows for the large-scale production of specific DNA sequences.
  • The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market.
  • Applied DNA has also established a COVID-19 diagnostic and testing offering that is in the early stages of commercialization and is grounded in the Companys deep expertise in DNA.

BioFlyte Launches First Field Deployable Airborne COVID-19 Detection System to Improve School and Workplace Safety

Retrieved on: 
Wednesday, May 26, 2021
Other Health, General Health, Medical devices, Technology, Other Education, Infectious diseases, Education, Science, Biotechnology, Other Technology, Other Science, Health, Articles, Science and technology, Technology, Amplifiers, Biotechnology, Hoffmann-La Roche, Molecular biology, Polymerase chain reaction, Joint Electronics Type Designation System, Sampling

BioFlyte , a biodetection company with a new class of fieldable biological threat collection, detection, and identification solutions, today announced the launch of the Sentinel Airborne COVID-19 Detection System for real-world surveillance of airborne coronavirus and other respiratory pathogens.

Key Points: 
  • BioFlyte , a biodetection company with a new class of fieldable biological threat collection, detection, and identification solutions, today announced the launch of the Sentinel Airborne COVID-19 Detection System for real-world surveillance of airborne coronavirus and other respiratory pathogens.
  • The Sentinel solution includes BioFlytes BioCapture z720 handheld air sampler and the BioFire Defense, Inc. FilmArray PCR sample analysis system.
  • Other airborne coronavirus sampling, detection and identification systems are laboratory-based and require a day for shipment and processing at an offsite lab to determine results.
  • "The BioFlyte Sentinel solution not only delivers significant cost savings for clients, it also helps ensure workplace safety, said Morgan Fisher, Vice President at CERI.

DGAP-News: SYNLAB and Hospital District of Helsinki and Uusimaa extend partnership for comprehensive PCR-testing for SARS-CoV-2 in Finland

Retrieved on: 
Wednesday, May 26, 2021
Amplifiers, Biotechnology, Hoffmann-La Roche, Molecular biology, Polymerase chain reaction, Lehtonen, Natural sciences, Life sciences, Science and technology

The cooperation will strengthen the capabilities of the Finnish healthcare system in the COVID- 19 response, and it will further increase protection for the Finnish people.

Key Points: 
  • The cooperation will strengthen the capabilities of the Finnish healthcare system in the COVID- 19 response, and it will further increase protection for the Finnish people.
  • In close collaboration, SYNLAB and HUS will analyse about 5,000 - 20,000 PCR-tests per day from individuals sampled all over Finland.
  • We will spare no effort to support the Finnish healthcare system both in the COVID-19 response and "back to normal" phase.
  • Lasse Lehtonen, Director of Diagnostic services in HUS, sees the continuation of the collaboration being positive for both parties.

Spartan Medical's Proven Back-To-School Testing Solution Update

Retrieved on: 
Tuesday, May 25, 2021
Branches of biology, Articles, Biology, Biotechnology, Molecular biology, COVID-19 testing, Polymerase chain reaction, Sparta

This week, Spartan Medical is launching its college and university Toolbox as part of a comprehensive, turn-key testing solution for Colleges and Universities .Schools can utilize some of these tools a la carte or as a full-service offering through Spartan Medical.

Key Points: 
  • This week, Spartan Medical is launching its college and university Toolbox as part of a comprehensive, turn-key testing solution for Colleges and Universities .Schools can utilize some of these tools a la carte or as a full-service offering through Spartan Medical.
  • "Many schools are looking for technology to link point-of-care (POC) antigen rapid testing used for screening with base-line or confirmatory RT-PCR testing to the same individual" states Eric Jania, Director of COVID-19 Testing Solutions.
  • Mr. Proffitt continued, "Spartan Medical can be relied upon as your tip of the spear resource and full solution to meet the ever-changing needs this pandemic has created.
  • Much more to follow, as we fine tune a sustainable health assessment package, with result-based recommendations, for our customer's continued safety."

AvantGen receives an award from the NIH/RADx to commercialize its anti-SARS-CoV-2 nucleocapsid antibodies for ultra-high sensitivity lateral flow assay development

Retrieved on: 
Tuesday, May 25, 2021
Branches of biology, Natural sciences, Biology, Biotechnology, Molecular biology, Immunologic tests, Chromatography, Medical terminology, Rapid antigen test, Lateral flow test, Polymerase chain reaction, LFA

A pair of the antibody clones has been evaluated extensively in a rapid lateral flow assay (LFA) format for the detection of SARS-CoV-2 N protein.

Key Points: 
  • A pair of the antibody clones has been evaluated extensively in a rapid lateral flow assay (LFA) format for the detection of SARS-CoV-2 N protein.
  • The LFA test can detect N protein in clinical samples (n=55; Ct values 14-38) with 100% sensitivity.
  • We are extremely pleased to see that our rapid test exhibits an ultra-high sensitivity similar to that of the CDCs PCR test.
  • With the funding from RADx, we look forward to the further development of rapid antigen tests with these antibodies.

MicroGenDX is Introducing PerioDX, the First Commercially Available Saliva-Based qPCR+NGS Test for Oral Health

Retrieved on: 
Monday, May 24, 2021
Articles, Laboratory techniques, Molecular biology, Science and technology, Natural sciences, Polymerase chain reaction, Biotechnology, Periodontal disease, Peri-implantitis, Real-time polymerase chain reaction, Periodontology

PerioDX is the first commercially available saliva-based periodontal test to combine quantitative polymerase chain reaction (qPCR) and NGS technology for comprehensive DNA diagnostic results.

Key Points: 
  • PerioDX is the first commercially available saliva-based periodontal test to combine quantitative polymerase chain reaction (qPCR) and NGS technology for comprehensive DNA diagnostic results.
  • Until now, only very limited PCR panel tests were commercially available to periodontal clinicians.
  • The introduction of the PerioDX test provides much-needed diagnostic support for oral health.
  • Certain oral microbes and microbial overgrowths cause inflammation and infection, contributing to the advancement and chronicity of periodontal disease and peri-implantitis.

Oligonucleotide Synthesis Markets, 2026 by Product (Drug, Synthesized Oligos (Primer, Probe), Reagents), Type (Custom, Predesign), Application (Therapeutic (ASO, siRNA), Research (PCR), Diagnostic) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 19, 2021
Health, Genetics, Branches of biology, Biology, Life sciences, Molecular biology, Laboratory techniques, Biotechnology, Nucleic acids, Molecular genetics, Oligonucleotide, Artificial gene synthesis, Polymerase chain reaction, Primer

By product, the synthesized oligonucleotides market is segmented into primers, probes, DNA oligos, RNA oligos, and other synthesized oligos such as BNA & LNA oligos.

Key Points: 
  • By product, the synthesized oligonucleotides market is segmented into primers, probes, DNA oligos, RNA oligos, and other synthesized oligos such as BNA & LNA oligos.
  • In 2020, the primers segment accounted for the fastest growing segment of this market, as they are used in various applications such as PCR, sequencing, gene synthesis, and cloning applications, among others.\nBased on application, the oligonucleotide synthesis market is segmented into therapeutic, research, and diagnostic applications.
  • The therapeutic application segment is further segmented into Antisense oligonucleotide-based therapies, siRNAi oligonucleotide-based therapies, and CpG oligonucleotide-based therapies.
  • Factors such as growing R&D funding, rising product availability, lower outsourcing costs, increasing research activities, increasing applications of oligos in molecular diagnostics & therapeutics, and the rising awareness of oligonucleotides are expected to drive market growth.\nNorth America accounted for the largest market share.

GT Molecular Launches Highly Sensitive Multiplexed PCR Tests for the Indian Coronavirus Variant

Retrieved on: 
Wednesday, May 19, 2021
Molecular biology, Laboratory techniques, Natural sciences, Branches of biology, Biology, Polymerase chain reaction, Biotechnology, Digital polymerase chain reaction, Real-time polymerase chain reaction, Reverse transcription polymerase chain reaction, Variants of SARS-CoV-2, Wastewater-based epidemiology

b"FORT COLLINS, Colo., May 19, 2021 /PRNewswire/ -- GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels for clinical labs, has started shipping its sensitive PCR tests to monitor the coronavirus variant, B.1.617.

Key Points: 
  • b"FORT COLLINS, Colo., May 19, 2021 /PRNewswire/ -- GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels for clinical labs, has started shipping its sensitive PCR tests to monitor the coronavirus variant, B.1.617.
  • The virus was first spotted in India and upgraded to a global variant of concern by the WHO.
  • It is sometimes referred to as the double mutant because it contains two mutations of concern and has been reported to be highly contagious and potentially capable of evading the immune system.\nA national wastewater-based epidemiology testing service in which sewage from communities around the country is tested for the presence of the key mutations that define the B.1.617 double mutant variant from India.\nUltrasensitive RT-PCR and dPCR reagent kits to empower academic, commercial, and public testing laboratories:\nThese new offerings add to GT Molecular's growing molecular assay catalog that includes SARS-CoV-2 multi-variant tests, cancer panels, multiplexed pathogen panels for clinical labs and quantitative standards.\nGT Molecular is a leader in providing highly customizable, ultrasensitive digital PCR and qPCR tests.
  • GTM's molecular app technology is an easy-to-use, end-to-end solution for rapid deployment and provides reliable and consistent measurements while detecting as little as 1-3 molecules of target nucleic acid.\n"

FastMed Now Offers Patients Rapid COVID-19 Antibody Testing

Retrieved on: 
Tuesday, May 18, 2021
Branches of biology, Medical specialties, Biology, Biotechnology, Molecular biology, Immunology, COVID-19, Public health, Zoonoses, Antibody, Polymerase chain reaction, COVID-19 testing

b'PHOENIX, May 18, 2021 /PRNewswire-PRWeb/ --FastMed, one of the nation\'s largest urgent care providers, now offers rapid antibody testing at all its 105 clinics across Arizona, North Carolina and Texas.

Key Points: 
  • b'PHOENIX, May 18, 2021 /PRNewswire-PRWeb/ --FastMed, one of the nation\'s largest urgent care providers, now offers rapid antibody testing at all its 105 clinics across Arizona, North Carolina and Texas.
  • Patients will receive results within an hour, whereas other antibody results could take up to several days.\n"The COVID-19 antibody test offered at FastMed detects both nucleocapsid as well as spike protein antibodies and can determine antibody response both to infection and vaccination," said Lane Tassin, M.D., co-chief medical officer at FastMed.
  • "Many patients may be reassured or take comfort in the knowledge that they likely have some degree of protection against a potentially severe illness.
  • Besides an RT-PCR test where the results are available in a few days, FastMed offers two rapid testing options that produce results while patients are still in its clinics.\nAll of FastMed\'s COVID-19 diagnostic tests are covered by insurance, but self-pay options are also available.